Back once again with a 'Play of the Week' Annual Review. The whole purpose of the 'Play of the Week' Annual Reviews is to show readers the long-term success of the "Divi-X" System compared to not using the "Divi-X" System. So, without further delay, let's see how our 'Play of the Week' investment fared in its first full year of trading in our Annual Review of Glaxo SmithKline plc (ADR), chosen back on March 16th, 2016.
The Dividend Times, LLC
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.